Cargando…
Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products
Autores principales: | Girman, Cynthia J., Ritchey, Mary E., Lo Re, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320939/ https://www.ncbi.nlm.nih.gov/pubmed/35471704 http://dx.doi.org/10.1002/pds.5444 |
Ejemplares similares
-
Considerations in characterizing real‐world data relevance and quality for regulatory purposes: A commentary
por: Girman, Cynthia J., et al.
Publicado: (2018) -
Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe
por: Cave, Alison, et al.
Publicado: (2019) -
Transferability of real-world data across borders for regulatory and health technology assessment decision-making
por: Jaksa, Ashley, et al.
Publicado: (2022) -
Application of Epidemiological Data for Decision Making: Health Claims
por: Schneeman, Barbara O.
Publicado: (2010) -
The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR
por: Khunti, Kamlesh, et al.
Publicado: (2023)